Encision (OTCMKTS:ECIA – Get Free Report) announced its quarterly earnings data on Wednesday. The medical device company reported ($0.03) earnings per share for the quarter, Zacks reports. Encision had a negative net margin of 6.05% and a negative return on equity of 22.33%.
Encision Stock Performance
Shares of ECIA stock traded down $0.04 on Wednesday, hitting $0.15. 5,500 shares of the stock were exchanged, compared to its average volume of 3,924. The firm’s 50 day moving average is $0.18 and its two-hundred day moving average is $0.26. Encision has a one year low of $0.10 and a one year high of $0.49. The firm has a market capitalization of $2.53 million, a PE ratio of -5.00 and a beta of 0.87. The company has a current ratio of 2.28, a quick ratio of 0.91 and a debt-to-equity ratio of 0.09.
About Encision
Encision, Inc is a U.S.-based medical device company specializing in the development and commercialization of safety solutions for electrosurgery. Founded in the early 1990s, the company’s core mission is to reduce the risk of unintended thermal injuries during surgical procedures by controlling stray electrical current. Encision’s operations focus on research, design, and manufacturing of proprietary instruments and monitoring systems that integrate seamlessly with existing surgical equipment.
At the heart of Encision’s product offering is its Active Electrode Monitoring (AEM) platform.
Read More
- Five stocks we like better than Encision
- This $15 Stock Could Go Down as the #1 Stock of 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- What a Former CIA Agent Knows About the Coming Collapse
- They just tried to kill gold
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Encision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encision and related companies with MarketBeat.com's FREE daily email newsletter.
